Allspring Global Investments’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-38,821
Closed -$1.47M 2397
2024
Q3
$1.47M Buy
38,821
+38,547
+14,068% +$1.58M ﹤0.01% 1238
2024
Q2
$12.4K Sell
274
-550
-67% -$25.3K ﹤0.01% 2183
2024
Q1
$40K Sell
824
-13,082
-94% -$641K ﹤0.01% 1997
2023
Q4
$745K Sell
13,906
-21,541
-61% -$1.09M ﹤0.01% 1412
2023
Q3
$2.08M Sell
35,447
-11,450
-24% -$716K ﹤0.01% 1183
2023
Q2
$2.96M Sell
46,897
-2,832
-6% -$180K ﹤0.01% 1125
2023
Q1
$3.13M Sell
49,729
-4,431
-8% -$264K 0.01% 1121
2022
Q4
$2.88M Buy
54,160
+2,450
+5% +$133K ﹤0.01% 1138
2022
Q3
$2.9M Sell
51,710
-8,626
-14% -$570K 0.01% 1127
2022
Q2
$4.37M Sell
60,336
-1,105
-2% -$82.3K 0.01% 1025
2022
Q1
$4.88M Buy
61,441
+7,054
+13% +$636K 0.01% 1154
2021
Q4
$5.5M Buy
+54,387
New +$5.43M 0.01% 1144

Other funds holding USNA

Allspring Global Investments's USNA Position: Q4 2024 in Review

Allspring Global Investments sold out of Usana Health Sciences (USNA) in Q4 2024, closing a stake of 38,821 shares — an estimated $1.47M sold.

Allspring Global Investments first reported a position in USNA in Q4 2021 and held it in 12 quarters. The position peaked at $5.5M in Q4 2021. 152 funds tracked by Wall St. Rank hold USNA as of Q4 2024.

  • Allspring Global Investments reported no remaining Usana Health Sciences position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 38,821 Usana Health Sciences shares in Q4 2024, an estimated $1.47M.
  • Allspring Global Investments first reported a position in Usana Health Sciences in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Usana Health Sciences position peaked at $5.5M in Q4 2021.
  • 152 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.